Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
| ▸ | ACACB | O00763 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL610055 | 0.87 | ALDH1A1 (0.41) | HTTHDAC3HDAC1HDAC2ALDH1A1 | |
| SCHEMBL308513 | 0.83 | HTT (0.56) | HTTCA1CA2SMN1; SMN2ALDH1A1 | |
| SCHEMBL18135323 | 0.83 | HTT (0.39) | HTTCA1CA2SMN1; SMN2ALDH1A1 | |
| SCHEMBL22372421 | 0.82 | HTT (0.35) | HTTCA1CA2SMN1; SMN2ALDH1A1 | |
| SCHEMBL18135322 | 0.82 | HTT (0.35) | HTTCA1CA2SMN1; SMN2TSHR | |
| SCHEMBL17981526 | 0.81 | THRB (0.35) | HTTCA1CA2ALDH1A1TSHR | |
| SCHEMBL30181660 | 0.81 | HTT (0.48) | HTTCA1CA2ALDH1A1TSHR | |
| SCHEMBL18525607 | 0.81 | HTT (0.38) | HTTCA1CA2SMN1; SMN2ALDH1A1 | |
| SCHEMBL305795 | 0.80 | KMT2A (0.37) | HTTCA1CA2SMN1; SMN2ALDH1A1 | |
| SCHEMBL17231843 | 0.80 | LMNA (0.40) | HTTCA1CA2SMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8956799-B2 | Photoacid generator and photoresist comprising same | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2015-02-17 | — | — | US | disclosed |
| US-20130171567-A1 | PHOTOACID GENERATOR AND PHOTORESIST COMPRISING SAME | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2013-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130171567-A1 | PHOTOACID GENERATOR AND PHOTORESIST COMPRISING SAME | F10, C1S, H1-0 | HTT 2724/4885CA1 695/4885CA2 434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.